Urgent Threats
■ Carbapenem-resistant Acinetobacter
■ Candida auris (C. auris)
■ Clostridioides difficile (C. difficile)
■ Carbapenem-resistant Enterobacteriaceae (CRE)
■ Drug-resistant Neisseria gonorrhoeae (N. gonorrhoeae)
Serious Threats
■ Drug-resistant Campylobacter
■ Drug-resistant Candida
■ Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae
■ Vancomycin-resistant Enterococci (VRE)
■ Multidrug-resistant Pseudomonas aeruginosa (P. aeruginosa)
■ Drug-resistant nontyphoidal Salmonella
■ Drug-resistant Salmonella serotype Typhi
■ Drug-resistant Shigella
■ Methicillin-resistant Staphylococcus aureus (MRSA)
■ Drug-resistant Streptococcus pneumoniae (S. pneumoniae)
■ Drug-resistant Tuberculosis (TB)
Concerning Threats
■ Erythromycin-resistant group A Streptococcus
■ Clindamycin-resistant group B Streptococcus
This is what ATH has to fight against these threats:
Bohlmann et al paper (gram-positive bacteria): PBT2 exhibits antibacterial activity and disrupts cellular homeostasis in erythromycin-resistant group A Streptococcus (GAS), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus (VRE).
De Oliviera paper (gram-negative bacteria) demonstrated the efficacy that PBT2 can break the resistance to polymyxin class antibiotics in Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa.
Jen FE, El-Deeb IM et al paper about PBT2 in gonorrhea.
I would expect some more research is still on the way to fill the caps of PBT2 on the list of CDC.
- Forums
- ASX - By Stock
- ATH
- Antibiotic-resistant problem: Urgent, serious and concerns of CDC (USA)
Antibiotic-resistant problem: Urgent, serious and concerns of CDC (USA)
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $545 | 109K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 40400743 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 19382520 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
45 | 40400743 | 0.005 |
38 | 61208682 | 0.004 |
47 | 44688315 | 0.003 |
16 | 32953014 | 0.002 |
12 | 96270101 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 19382520 | 24 |
0.007 | 18160710 | 20 |
0.008 | 15309321 | 19 |
0.009 | 7171000 | 8 |
0.010 | 2759026 | 5 |
Last trade - 09.59am 23/05/2024 (20 minute delay) ? |
|
|||||
Last
0.6¢ |
  |
Change
-0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.6¢ | 0.6¢ | 0.6¢ | 20000 | ||
Last updated 11.42am 23/05/2024 ? |
Featured News
ATH (ASX) Chart |